Hypromellose eye drops
Generic name
Hypromellose eye drops
Brand name
ATC Code
S01XA20
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
There is no systemic absorption during ocular use of hypromellose.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Reduced tear secretion/dehydration |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OTHER OPHTHALMOLOGICALS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| OVERIGE MIDDELEN VOOR OOGHEELKUNDIG GEBRUIK | ||
|---|---|---|
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA21 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA | ||
| Other ophthalmologicals | ||
|---|---|---|
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA21 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA | ||
Reference
- Bausch & Lomb Pharma NV, SmPC Artelac (RVG 32371) 14-08-2015, www.geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
